Get the Stockscreener App
1.97
1.03%
0.02
After Hours:
1.95
-0.02
-1.02%
Nkarta Inc stock is traded at $1.97, with a volume of 957.98K.
It is up +1.03% in the last 24 hours and down -8.37% over the past month.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
See More
Previous Close:
$1.95
Open:
$1.95
24h Volume:
957.98K
Relative Volume:
1.13
Market Cap:
$139.92M
Revenue:
-
Net Income/Loss:
$-117.50M
P/E Ratio:
-0.8208
EPS:
-2.4
Net Cash Flow:
$-114.31M
1W Performance:
-5.29%
1M Performance:
-8.37%
6M Performance:
+5.91%
1Y Performance:
-41.19%
1-Day Range:
$1.905
$2.005
1-Week Range:
$1.905
$2.1795
52-Week Range:
$1.31
$3.8099
Nkarta Inc Stock (NKTX) Company Profile
Name
Nkarta Inc
Sector
Industry
Phone
(925) 407-1049
Address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Compare NKTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
1.97 | 138.50M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.25 | 105.80B | 11.74B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
646.87 | 67.70B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
440.49 | 57.41B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
851.01 | 51.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.68 | 39.86B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-09-24 | Initiated | Rodman & Renshaw | Buy |
| Aug-14-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-22-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-10-22 | Initiated | Canaccord Genuity | Buy |
| Jul-28-22 | Initiated | Needham | Buy |
| Jul-18-22 | Initiated | SVB Leerink | Outperform |
| Mar-11-22 | Initiated | Raymond James | Outperform |
| Mar-08-22 | Initiated | H.C. Wainwright | Buy |
| Jan-06-22 | Initiated | William Blair | Outperform |
| Nov-18-21 | Initiated | SMBC Nikko | Outperform |
| Jul-16-21 | Initiated | Oppenheimer | Outperform |
| Aug-04-20 | Initiated | Cowen | Outperform |
| Aug-04-20 | Initiated | Evercore ISI | Outperform |
| Aug-04-20 | Initiated | Mizuho | Buy |
| Aug-04-20 | Initiated | Stifel | Buy |
View All
Nkarta Inc Stock (NKTX) Latest News
How Nkarta Inc. stock benefits from strong dollarWeekly Investment Report & Fast Momentum Entry Tips - newser.com
Will Nkarta Inc. stock beat EPS estimatesPortfolio Risk Summary & Low Drawdown Momentum Trade Ideas - newser.com
Will Nkarta Inc. stock split again soonNew Guidance & Intraday High Probability Alerts - newser.com
Will Nkarta Inc. stock deliver strong dividend growthMarket Activity Recap & Community Verified Watchlist Alerts - newser.com
What momentum indicators show for Nkarta Inc. stockJuly 2025 Movers & Daily Risk Controlled Trade Plans - newser.com
Can Nkarta Inc. stock surprise with earnings upsideQuarterly Investment Review & Daily Price Action Insights - fcp.pa.gov.br
Nkarta Inc. stock prediction for this week2025 Market Overview & Risk Managed Trade Strategies - newser.com
Published on: 2025-11-05 21:47:08 - newser.com
Is it time to cut losses on Nkarta Inc.July 2025 Action & High Accuracy Trade Signal Alerts - newser.com
Is Nkarta Inc. stock a safe haven assetJobs Report & Technical Analysis for Trade Confirmation - fcp.pa.gov.br
Will Nkarta Inc. stock gain from government policiesExit Point & High Win Rate Trade Alerts - newser.com
Risk adjusted return profile for Nkarta Inc. analyzedDip Buying & Verified Momentum Stock Watchlist - newser.com
Using Python tools to backtest Nkarta Inc. strategies2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
Can machine learning forecast Nkarta Inc. recoveryWeekly Stock Recap & High Return Stock Watch Alerts - newser.com
Its Stock Has Paid Off Big Time For Nkarta Inc - setenews.com
Real time alert setup for Nkarta Inc. performanceEarnings Trend Report & Weekly Breakout Watchlists - newser.com
Nkarta Inc. stock chart pattern explainedBuy Signal & Precise Swing Trade Alerts - newser.com
Is Nkarta Inc. stock supported by strong fundamentalsIPO Watch & Safe Capital Preservation Plans - newser.com
Nkarta Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Will Nkarta Inc. stock continue upward momentumRisk Management & Community Consensus Stock Picks - newser.com
Nkarta Inc Stock Analysis and ForecastGrowth vs. Value Investing & Low Cost Market Strategies - earlytimes.in
Weiss Ratings Reaffirms "Sell (D-)" Rating for Nkarta (NASDAQ:NKTX) - MarketBeat
What drives Nkarta Inc stock priceRisk Mitigation Techniques & Low Entry Cost Investments - earlytimes.in
Nkarta Inc Stock (NKTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):